Title

Phase 2 Study of Indomethacin Capsules to Treat Dental Pain
A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin Test Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars
  • Phase

    Phase 2
  • Study Type

    Interventional
  • Intervention/Treatment

    indomethacin celecoxib ...
  • Study Participants

    203
The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.
Study Started
Aug 31
2009
Primary Completion
Dec 31
2009
Study Completion
Dec 31
2009
Results Posted
Mar 30
2012
Estimate
Last Update
May 22
2012
Estimate

Drug Celecoxib 400 mg

Capsules 2 x 200 mg Single-Dose

Drug Placebo

Capsules 2 Single-Dose

Drug Indomethacin Test (lower dose)

20-mg single dose

Drug Indomethacin Test (upper dose)

40-mg single dose

Indomethacin Test (upper dose) Experimental

Single dose

Celecoxib 400 mg Active Comparator

Placebo Placebo Comparator

Indomethacin Test (lower dose) Experimental

Criteria

Inclusion Criteria:

Patient is male or female between 18 and 50 years of age
For women of child-bearing potential: a woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control
Patient requires extraction of 2 or more third molars
Patient must be willing to stay at the study site for at least 8 hours after dosing of the study drug

Exclusion Criteria:

Patient has hypersensitivity, allergy, or clinically significant intolerance to any medications to be used in the study, or related drugs
Patient has a current disease or history of a disease that will impact the study or the patient's well-being
Patient has used or intends to use any of the medications that are prohibited by the protocol
Patient has a history of drug or alcohol abuse or dependence, or patient has a positive urine drug screen or alcohol breathalyzer test
Patient has taken another investigational drug within 30 days prior to Screening

Summary

Indomethacin Test (Lower Dose)

Indomethacin Test (Upper Dose)

Celecoxib 400 mg

Placebo

All Events

Event Type Organ System Event Term Indomethacin Test (Lower Dose) Indomethacin Test (Upper Dose) Celecoxib 400 mg Placebo

Total Patient Pain Relief Over 0 to 8 Hours.

Total patient pain relief was assessed as a time-weighted sum of the patient pain assessments at each individual time point from 0-8 hours. Values for TOTPAR are measured from 0 to 4 on the Pain Relief Scale 0 None Min; 1 A little; 2 Some; 3 A lot; 4 Complete Max The TOTPAR is a weighted measure of the observations; the minimum possible value is 0 and the maximum possible value is 32.

Indomethacin Test (Lower Dose)

10.794
units on a scale (Least Squares Mean)
95% Confidence Interval: 8.131 to 13.456

Indomethacin Test (Upper Dose)

12.564
units on a scale (Least Squares Mean)
95% Confidence Interval: 9.928 to 15.2

Celecoxib 400 mg

14.822
units on a scale (Least Squares Mean)
95% Confidence Interval: 12.185 to 17.46

Placebo

3.019
units on a scale (Least Squares Mean)
95% Confidence Interval: 0.381 to 5.656

Total

203
Participants

Age Continuous

22.1
years (Mean)
Standard Deviation: 3.38

Age, Categorical

Region of Enrollment

Sex: Female, Male

Overall Study

Indomethacin Test (Lower Dose)

Indomethacin Test (Upper Dose)

Celecoxib 400 mg

Placebo